Login:
 
Savill P. Target oral anticoagulant therapy in AF patients at high risk. Practitioner January 2020;264(1833):5

Target oral anticoagulant therapy in AF patients at high risk

23 Jan 2020Registered users

Almost 50% of atrial fibrillation patients at very low thromboembolic risk are treated with oral anticoagulants contrary to guideline recommendations, a large global study has found.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

To buy this article (£25+tax) copy the article citation above and click Buy article